Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Epidemiological studies have established that the epsilon 4 allele of the ApoE gene (ApoE4) constitutes an important risk factor for Alzheimer's disease and might influence the outcome of central nervous system injury. The mechanism by which ApoE4 contributes to the development of neurodegeneration remains unknown. To test one hypothesis or mode of action of ApoE, we generated transgenic mice that overexpressed human ApoE4 in different cell types in the brain, using four distinct gene promoter constructs. Many transgenic mice expressing ApoE4 in neurons developed motor problems accompanied by muscle wasting, loss of body weight, and premature death. Overexpression of human ApoE4 in neurons resulted in hyperphosphorylation of the microtubule-associated protein tau. In three independent transgenic lines from two different promoter constructs, increased phosphorylation of protein tau was correlated with ApoE4 expression levels. Hyperphosphorylation of protein tau increased with age. In the hippocampus, astrogliosis and ubiquitin-positive inclusions were demonstrated. These findings demonstrate that expression of ApoE in neurons results in hyperphosphorylation of protein tau and suggests a role for ApoE in neuronal cytoskeletal stability and metabolism.

[1]  D. Carmelli,et al.  Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele , 1994 .

[2]  M. Gearing,et al.  Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease , 1996 .

[3]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[4]  R. Mahley,et al.  Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.

[5]  T. Iwatsubo,et al.  Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex , 1997, Neuroreport.

[6]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[7]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[8]  E. Hall,et al.  Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia. , 1996, Brain research. Molecular brain research.

[9]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[10]  A. Fagan,et al.  Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[11]  M. Tolar,et al.  Neurite Degeneration Elicited by Apolipoprotein E Peptides , 1994, Experimental Neurology.

[12]  B. Bahr,et al.  Age‐Related Phosphorylation and Fragmentation Events Influence the Distribution Profiles of Distinct Tau Isoforms in Mouse Brain , 1998, Journal of neuropathology and experimental neurology.

[13]  Jean-Claude Martinou,et al.  Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia , 1994, Neuron.

[14]  B. Hyman,et al.  A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele , 1996, Neurology.

[15]  The −491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEϵ4 allele and Alzheimer's Disease , 1999, Neuroscience Letters.

[16]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[17]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Michaelson,et al.  Phosphorylation of tau in apolipoprotein E-deficient mice , 1995, Neuroscience Letters.

[19]  D. Michaelson,et al.  Site‐Specific Dephosphorylation of Tau of Apolipoprotein E‐Deficient and Control Mice by M1 Muscarinic Agonist Treatment , 1999, Journal of neurochemistry.

[20]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[21]  A. Delacourte,et al.  ApoE Synthesis in Human Neuroblastoma Cells , 1997, Neurobiology of Disease.

[22]  J. Gilbert,et al.  Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.

[23]  M. Pericak-Vance,et al.  Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls , 1994, Experimental Neurology.

[24]  L. Mucke,et al.  Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: In vivo comparison of distinct GFAP‐lacZ transgenes , 1995, Glia.

[25]  A. Berns,et al.  Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[27]  J. Schwankhaus,et al.  A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease , 1995, Neuroscience Letters.

[28]  A. Smith,et al.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease , 1995, Neuroscience.

[29]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[30]  J. Brion,et al.  Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. , 1995, Neuroreport.

[31]  R. Demattos,et al.  A Test of the Cytosolic Apolipoprotein E Hypothesis Fails to Detect the Escape of Apolipoprotein E from the Endocytic Pathway into the Cytosol and Shows that Direct Expression of Apolipoprotein E in the Cytosol is Cytotoxic , 1999, The Journal of Neuroscience.

[32]  Margaret A. Pericak-Vance,et al.  Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.

[33]  R. Demattos,et al.  A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.

[34]  J. Victoroff,et al.  Increased Apolipoprotein E mRNA in the Hippocampus in Alzheimer Disease and in Rats after Entorhinal Cortex Lesioning , 1998, Experimental Neurology.

[35]  J. Gilbert,et al.  Regionally specific neuronal expression of human APOE gene in transgenic mice , 1998, Neuroscience Letters.

[36]  G. Evans,et al.  The mouse Thy-1.2 glycoprotein gene: complete sequence and identification of an unusual promoter. , 1986, Journal of immunology.

[37]  G. Evans,et al.  Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[39]  J. Hardy,et al.  Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. , 1997, Human molecular genetics.

[40]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[41]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[42]  Expression in brain of amyloid precursor protein mutated in the alpha‐secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. , 1996 .

[43]  K. Horsburgh,et al.  Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat , 1996, Neuropathology and applied neurobiology.

[44]  D. Bonthron,et al.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.

[45]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Jellinger,et al.  TAU AND UBIQUITIN IMMUNOREACTIVITY AT DIFFERENT STAGES OF FORMATION OF ALZHEIMER NEUROFIBRILLARY TANGLES , 1989, Progress in clinical and biological research.

[47]  L. Serneels,et al.  Targeted Inactivation of the Mouse α2-Macroglobulin Gene (*) , 1995, The Journal of Biological Chemistry.

[48]  D. Hanger,et al.  Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase mos , 1996, Neurobiology of Aging.

[49]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[50]  J. Brion,et al.  Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. , 1999, The American journal of pathology.

[51]  M. Rossor,et al.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.

[52]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease , 1994, Neuroscience Letters.

[53]  G. Getz,et al.  Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures , 1997, Journal of neurochemistry.

[54]  U. Wagner,et al.  Tau phosphorylation in transgenic mice expressing glycogen synthase kinase‐3β transgenes , 1997, Neuroreport.

[55]  A. Takahashi,et al.  Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus , 1996, Brain Research.

[56]  J. Morris,et al.  A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia , 1998, Nature Genetics.

[57]  A. Messing,et al.  GFAP promoter directs astrocyte-specific expression in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  H. Braak,et al.  High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.

[59]  J. Silver,et al.  Regulation of Thy-1 gene expression in transgenic mice , 1987, Cell.

[60]  J. Gilbert,et al.  Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.

[61]  M. Tolar,et al.  Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated , 1997, The Journal of Neuroscience.

[62]  G. Getz,et al.  Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity: Implications for Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[63]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[64]  N. Relkin,et al.  Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.

[65]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  D. Holtzman,et al.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  F. Pasquier,et al.  A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. , 1998, Human molecular genetics.

[68]  A. Delacourte,et al.  Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE , 1999, Neuroscience Letters.

[69]  J. Gilbert,et al.  Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice , 1998, Neurobiology of Aging.

[70]  A. Fagan,et al.  Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins , 1998, The Journal of Neuroscience.

[71]  K. Herrup,et al.  Expression of Thy-1/lacZ fusion genes in the CNS of transgenic mice. , 1994, Brain research. Molecular brain research.

[72]  M. Bullido,et al.  Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene , 1998, FEBS letters.

[73]  A. Roses,et al.  Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology. , 1998, Journal of neuropathology and experimental neurology.

[74]  M. Tolar,et al.  A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. , 1996, Neuroreport.

[75]  R. Morris,et al.  Thy-1, the enigmatic extrovert on the neuronal surface. , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[76]  J. Seidman,et al.  Cytoskeletal Changes in the Brains of Mice Lacking Calcineurin Aα , 1997, Journal of neurochemistry.

[77]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[78]  R. Martins,et al.  The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. , 1999, Neuroreport.

[79]  J. Hardy,et al.  Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. , 1998, Human molecular genetics.

[80]  D. Graham,et al.  Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.

[81]  W. White,et al.  Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. , 1997, The Annals of thoracic surgery.

[82]  K. Latham,et al.  Expression of X-linked genes in androgenetic, gynogenetic, and normal mouse preimplantation embryos. , 1995, Developmental genetics.